End-of-Life Dementia Care: Complete Funding Guide

End-of-life dementia care costs £1,400+ per week for specialist nursing supervision (Laing Buisson Care of Older People UK Market Report, 2024). NHS Continuing Healthcare can cover 100% of those costs with no means test — and end-of-life dementia frequently meets the criteria (NHS National Framework (2022)).

TL;DR: End-of-life dementia care averages £1,400+/week for specialist nursing supervision (Laing Buisson, 2024) — over £73,000/year. Advanced dementia typically qualifies for NHS Continuing Healthcare: 100% of costs funded, no means test. Fast Track CHC can be triggered by a GP within 24 hours at end of life. Most families discover this option only after months of paying privately.

End-of-Life Dementia Care: What It Involves

Understanding what care is needed — and whether the NHS should be funding it — matters at this stage more than at any other. NHS Continuing Healthcare exists precisely for situations like advanced dementia, where needs are overwhelmingly clinical in nature. Establishing whether that applies to your relative should be your first practical step.

Specifically, in physical terms, advanced dementia strips away the abilities most of us take for granted. The person loses the capacity to walk, speak, and eventually swallow safely. Every function that can deteriorate eventually does. What remains is a profound vulnerability that requires skilled, round-the-clock clinical management — not just personal care.

The nursing tasks involved are substantial:

• Aspiration risk management — safe swallowing becomes dangerous; nutrition may need to be delivered in modified forms, and every meal carries risk of aspiration pneumonia, which is one of the most common causes of death at this stage
• Skin integrity — immobility creates serious pressure sore risk; repositioning schedules, specialist mattresses, and wound care require nursing skill, not just care worker attention
• Continence management — full incontinence is typical and requires clinical management to prevent infection and maintain dignity
• Palliative symptom control — pain, agitation, and distress need active management; medication regimes at this stage are often complex and require regular review
• Comfort care — mouth care, positioning, managing terminal restlessness, liaising with family about the person's condition

As a result, most people with advanced dementia die in care homes. Death is usually from aspiration pneumonia, systemic infection, or organ failure — not from dementia itself in a technical sense, but from what dementia has done to the body.

This is not what people imagine when they picture dementia. The final stage is a medical condition requiring medical management.

How long does end-of-life dementia typically last?

There is no reliable answer that applies to everyone, and you should be cautious of anyone who gives you a confident number.

After diagnosis, average life expectancy is 8–10 years (Alzheimer's Society, Living with Dementia Report, 2023) — but that figure covers enormous individual variation. Some people live with dementia for twenty years. Others decline rapidly within two or three.

However, the end-stage phase — when swallowing and feeding difficulties emerge — typically lasts months, sometimes one to two years. The mean time from care home admission to death for someone with dementia is approximately two years (Laing Buisson Care of Older People UK Market Report, 2024), though again, individual cases vary widely.

The practical point is this: end of life in dementia is not a brief, discrete event. It is a prolonged stage that generates substantial ongoing costs. For families funding care privately, that duration matters enormously.

Who funds end-of-life dementia care?

Unless NHS Continuing Healthcare applies, the standard means test governs everything.

Under the Care Act 2014, anyone with assets above £23,250 must self-fund their care home placement entirely. Capital includes savings, investments, and — in most cases — property, unless a spouse or civil partner continues to live there. Once assets fall below £23,250 through spending on care, the local authority begins to contribute, up to a limit that still leaves the person paying a personal expenses allowance of £30.15 per week (DHSC, 2024–25).

Notably, from October 2025, the upper threshold rises from £23,250 to £100,000 under the Health and Care Act 2022, section 140. More people will retain partial local authority support for longer — but the principle remains the same: most people with significant assets will self-fund.

The cost of that self-funding is not modest. Specialist dementia care home fees run at £1,400+ per week (Laing Buisson Care of Older People UK Market Report, 2024) — over £73,000 per year. For a final stage lasting two years, that is £146,000 or more paid from private assets before any local authority support kicks in.

In practice, most families don't realise they can challenge care home funding arrangements until they have already been paying privately for months. This is the financial reality most families are not told about when a relative is placed in a care home.

NHS Continuing Healthcare changes the picture entirely. If criteria are met, the NHS funds 100% of the care home placement — nursing care, accommodation, and personal care — with no means test and no asset threshold.

See our full guide to CHC funding for how the assessment process works.

Does end-of-life dementia qualify for NHS Continuing Healthcare?

Frequently, yes. That is not a marketing claim — it follows directly from the clinical profile of advanced dementia.

CHC eligibility under the National Framework for NHS Continuing Healthcare (2022) requires that the person has a "primary health need": that their overall care needs are driven primarily by their health condition, not by social or personal care needs. The assessment scores the person across twelve care domains.

End-stage dementia typically generates Priority or Severe scores across multiple domains simultaneously:

• Cognition — complete loss of orientation, memory, and decision-making capacity
• Communication — absent or severely reduced, often to non-verbal
• Behaviour — distress, agitation, and resistiveness that previously required active management (now often absent due to physical incapacity)
• Continence — full incontinence requiring clinical management
• Nutrition and hydration — swallowing difficulties and aspiration risk requiring clinical oversight
• Skin integrity — high pressure sore risk from immobility, requiring active prevention and wound management
• Medication — complex palliative regimes, regular review needed

Under the National Framework for NHS Continuing Healthcare (2022), a single Priority domain or two Severe domains strongly indicates a primary health need. In end-stage dementia, it is common to see several domains at Priority or Severe simultaneously.

Around 60,000 people in England receive CHC at any one time (NHS Continuing Healthcare Statistics, 2023–24). Research by Independent Age found that many eligible people are never assessed — they self-fund to the end without anyone suggesting CHC was an option (Independent Age, Turned Away: How the NHS is Failing People Who Need Continuing Healthcare, 2023).

If you have not yet requested an assessment, read our page on whether dementia qualifies for CHC for a detailed breakdown of how the criteria apply.

Getting a CHC Assessment at End of Life

You do not have to wait for the care home, GP, or hospital to suggest it. You can request one yourself, in writing, from your local Integrated Care Board (ICB).

There are two routes at end of life:

Fast Track CHC is the more urgent option. Under National Framework for NHS Continuing Healthcare (2022), paragraph 62, Fast Track is available for people with a rapidly deteriorating condition who may be entering a terminal phase. A GP or consultant can request it. The target decision time is 24 hours. If Fast Track is granted, the NHS pays 100% immediately — no multi-disciplinary team meeting is required.

In our experience, families who explicitly ask the GP whether Fast Track is appropriate are significantly more likely to have it triggered than those who wait for the clinical team to raise it. Put the request in writing.

Standard CHC assessment follows if Fast Track is not triggered or is declined. An MDT assessment should take place within 28 days under the National Framework for NHS Continuing Healthcare (2022). A family member with Lasting Power of Attorney for Health and Welfare should attend and can contribute evidence.

To support either route, gather:

• Recent clinical assessments and care plans from the care home
• Medication lists and any palliative care referral letters
• A care diary if you have kept one — daily observations of the person's condition, distress, and nursing interventions
• Any correspondence from the GP, consultant, or community nursing team

What happens if CHC is refused for end-of-life dementia?

A refusal is not the end of the process.

Request formal ICB reconsideration. This is the first stage of the NHS appeals process. Submit it in writing, with additional clinical evidence — care home records, GP statements, nursing assessments. Focus on the specific domains where you believe the score was underestimated.

Escalate to NHS England. If the ICB reconsideration upholds the refusal, you can appeal to NHS England. An independent panel reviews the case.

Parliamentary and Health Service Ombudsman. If NHS England's process fails to resolve the matter, the Ombudsman is the final route for unresolved NHS complaints.

Retrospective CHC assessment. If your relative has since died, the process does not close. Families can still request a retrospective CHC assessment for the period when needs were present through NHS England's retrospective review process. See our guide to dementia care home fees for what those sums typically look like.

The appeals process requires persistence and documentation. For instance, ICBs frequently decline CHC at first instance even when the clinical case is strong. That is precisely why families who gather evidence, understand the framework, and appeal — rather than accepting the first decision — recover costs that others lose permanently.